Business

Why Allogene Therapeutics (ALLO) Says Its Lead Cancer Program Is Still on Track in 2026

Mar 29, 2026 - 23:00
 0
Why Allogene Therapeutics (ALLO) Says Its Lead Cancer Program Is Still on Track in 2026
Read More

Related Posts

Airlines issue travel waivers due to London's Heathrow Airport shutdown

Airlines issue travel waivers due to London's Heathrow ...

Mar 21, 2025  0

Meta global affairs chief says decision not to offer Instagram, Facebook in China helps defend free expression

Meta global affairs chief says decision not to offer In...

Mar 21, 2025  10

The five keys to unlock homeownership for emerging buyers

The five keys to unlock homeownership for emerging buyers

Mar 21, 2025  1

Disney investor pledges to continue fight as shareholders reject proposal to distance company from LGBT group

Disney investor pledges to continue fight as shareholde...

Mar 21, 2025  4

ZipRecruiter CTO Boris Shimanovsky sells $22,788 in stock

ZipRecruiter CTO Boris Shimanovsky sells $22,788 in stock

Mar 21, 2025  0

Businesses may have to pass high beef prices on to consumers

Businesses may have to pass high beef prices on to cons...

Mar 21, 2025  4